The REbif® vs Glatiramer Acetate in Relapsing Multiple Sclerosis Pharmacogenetics Trial
NCT01034579
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
324
Enrollment
INDUSTRY
Sponsor class
Conditions
Relapsing Multiple Sclerosis
Interventions
OTHER:
Blood sampling
OTHER:
Blood sampling
Sponsor
EMD Serono